Clonazepam Tablet
Product Images NDC 71335-0113

2 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 71335-0113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clonazepam Structural Formula (Fig 1)

Clonazepam Structural Formula (Fig 1)
Chemical structure diagram of the active ingredient clonazepam, showing its fused benzodiazepine ring system with nitro and chloro substituents on the aromatic rings.*
FDA Label Image

Label (Lbl713350113)

Label (Lbl713350113)
Clonazepam 0.5 mg tablet packaging label by Bryant Ranch Prepack, NDC 71335-0113. The label states it is comparable to Klonopin 0.5 mg tablets from Intas Pharmaceuticals Limited. It indicates the tablets are orange and round, with storage instructions at 20°-25°C (68°-77°F) and a warning that it may cause drowsiness. The package contains 20 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.